In contrast to circRELL1, mutations in the RELL1 protein may be pro-tumorigenic for gastric cancer, as the N255D mutation described previously for glioblastoma was also expressed in at least 30% of gastrointestinal tract cancer patients [71]. The gene discussed is RELL1; the disease is gastric cancer.